<DOC>
	<DOCNO>NCT00868933</DOCNO>
	<brief_summary>Nonalcoholic fatty liver disease ( NAFLD ) common chronic liver disease affluent country . It may progress cirrhosis liver cancer . At present , approved drug NAFLD . Although healthy diet exercise often recommend , little supportive evidence . Therefore , investigator plan conduct randomize controlled trial compare low glycemic index dietary intervention program simple lifestyle advice NAFLD patient . The primary endpoint resolution NAFLD . Non-invasive test use ass study subject . Proton-magnetic resonance spectroscopy use quantify hepatic triglyceride content , transient elastography use quantify liver fibrosis .</brief_summary>
	<brief_title>Low Glycemic Index Dietary Intervention Program Nonalcoholic Fatty Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Age 18 70 year Fatty liver protonmagnetic resonance spectroscopy , define hepatic triglyceride content 5 % Serum alanine aminotransferase ( ALT ) 30 U/L men 19 U/L woman Informed write consent obtain Positive hepatitis B surface antigen , antihepatitis C virus antibody , antinuclear antibody titer 1/160 Alcohol consumption 30 g per week men 20 g per week woman Alanine aminotransferase ( ALT ) 10 time upper limit normal Liver decompensation , evidence bilirubin 50 µmol/l , platelet count 100 × 10e9/l , prothrombin time 1.3 time upper limit normal , albumin 35 g/l , presence ascites varix Evidence hepatocellular carcinoma Terminal illness cancer , unless complete remission 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>